Vanguard Group Inc Cryo Cell International Inc Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Cryo Cell International Inc stock. As of the latest transaction made, Vanguard Group Inc holds 116,956 shares of CCEL stock, worth $916,935. This represents 0.0% of its overall portfolio holdings.
Number of Shares
116,956
Previous 116,848
0.09%
Holding current value
$916,935
Previous $744,000
17.2%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CCEL
# of Institutions
21Shares Held
1MCall Options Held
0Put Options Held
0-
Hamilton Lane Advisors LLC410KShares$3.21 Million3.11% of portfolio
-
Sfi Advisors, LLC Montclair, NJ165KShares$1.3 Million0.87% of portfolio
-
Massmutual Trust CO Fsb111KShares$870,5140.02% of portfolio
-
Geode Capital Management, LLC Boston, MA39.9KShares$312,5020.0% of portfolio
-
Northern Trust Corp Chicago, IL38.9KShares$304,9910.0% of portfolio
About CRYO CELL INTERNATIONAL INC
- Ticker CCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 8,519,250
- Market Cap $66.8M
- Description
- Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative med...